The effects of cardiovascular risk factor combined anti-platelet therapy and the risk of cerebrovascular events in patients with T2DM in an urban community over 96-months follow-up: The Beijing communities diabetes study 19-Reference-Cited by-同舟云学术

The effects of cardiovascular risk factor combined anti-platelet therapy and the risk of cerebrovascular events in patients with T2DM in an urban community over 96-months follow-up: The Beijing communities diabetes study 19

Published:2018-10 Issue: Volume:144 Page:236-244
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Zhang Xue-Lian,Fu Han-Jing,Yang Guang-Ran,Wan Gang,Li Dongmei,Zhu Liang-Xiang,Xie Rong-Rong,Lv Yu-Jie,Zhang Jian-Dong,Li Yu-Ling,Dai Qin-Fang,Ji Yu,Gao Da-yong,Cui Xue-Li,Liu De-Yuan,Yuan Shen-Yuan,Yuan Ming-Xia

Funder

Special Scientific Research on Capital Health Development

Beijing Municipal Science &Technology Commission

International Diabetes Federation

University of Rochester’s Clinical and Translational Science Award

National Center for Advancing Translational Sciences of the National Institutes of Health

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010;Yang;Lancet,2013